{
    "abstractText": "Endophytic fungi are an important resource for bioactive natural products. In this study, a new tryptophan derivative fusaconate A (1), and three pyridone alkaloids, including one new pyridone derivative 1\u2032-methoxy-6\u2032-epi-oxysporidinone (2) and two known ones (3\uf02d4) were identified from the endophytic fungus Fusarium concentricum which was isolated from the medicinal plant Anoectochilus roxburghii. Their structures were elucidated through extensive spectroscopic analysis, including HR-ESI-MS, 1D and 2D NMR. Compound 4 exhibited moderate cytotoxicities against HT29 and PC3 cells with IC50 values of 7.60 and 4.99 \u03bcM, respectively.",
    "authors": [
        {
            "affiliations": [],
            "name": "Xi-Lin Zhang"
        },
        {
            "affiliations": [],
            "name": "Bing-Guo Lu"
        },
        {
            "affiliations": [],
            "name": "Jian Bai"
        },
        {
            "affiliations": [],
            "name": "Ning Li"
        }
    ],
    "id": "SP:32c6bf02c66a787cec63cd038dd10de9050f285f",
    "references": [],
    "sections": [
        {
            "text": "Endophytic fungi are an important resource for bioactive natural products. In this study,\na new tryptophan derivative fusaconate A (1), and three pyridone alkaloids, including\none new pyridone derivative 1\u2032-methoxy-6\u2032-epi-oxysporidinone (2) and two known\nones (34) were identified from the endophytic fungus Fusarium concentricum which\nwas isolated from the medicinal plant Anoectochilus roxburghii. Their structures were\nelucidated through extensive spectroscopic analysis, including HR-ESI-MS, 1D and 2D\nNMR. Compound 4 exhibited moderate cytotoxicities against HT29 and PC3 cells with\nIC50 values of 7.60 and 4.99 \u03bcM, respectively.\nKeywords: Fusarium concentricum; Pyridone alkaloids; Endophytic fungi; Cytotoxicity\n*Corresponding authors: Jian Bai, E-mail: baijian@imm.ac.cn; Ning Li, E-mail:\nliningsypharm@163.com\nContents Table S1. The 1H (600 MHz) and 13C NMR (150 MHz) spectral data of compound 1 in CD3OD ........ 3 Table S2. The 1H (600 MHz) and 13C NMR (150 MHz) spectral data of compounds 24 in CD3OD .. 4 Table S3. Cytotoxicities (IC50 in M) for compound 1\u20124 ................................................................... 5 Figure S1. 1H\u22121H COSY and Key HMBC correlations of compound 1. ................................................ 6 Figure S2. Key 1H\u22121H COSY, HMBC and NOESY correlations of compound 2 .................................... 6 Figure S3. HR-ESI-MS spectrum of compound 1 ............................................................................... 7 Figure S4. UV spectrum of compound 1 ........................................................................................... 8 Figure S5. IR spectrum of compound 1 ............................................................................................. 8 Figure S6. 1H-NMR (600 MHz, CD3OD) spectrum of compound 1 .................................................... 9 Figure S7. 13C-NMR (150 MHz, CD3OD) spectrum of compound 1 ................................................... 9 Figure S8. HSQC (600 MHz, CD3OD) spectrum of compound 1 ...................................................... 10 Figure S9. 1H-1H COSY (600 MHz, CD3OD) spectrum of compound 1 ............................................. 10 Figure S10. HMBC (600 MHz, CD3OD) spectrum of compound 1 ................................................... 11 Figure S11. HR-ESI-MS spectrum of compound 2 ........................................................................... 12 Figure S12. UV spectrum of compound 2 ....................................................................................... 13 Figure S13. IR spectrum of compound 2 ......................................................................................... 13 Figure S14. 1H-NMR (600 MHz, CD3OD) spectrum of compound 2 ................................................ 14 Figure S15. 13C-NMR (150 MHz, CD3OD) spectrum of compound 2 ............................................... 14 Figure S16. Comparative 13C-NMR spectrum of compounds 2 and 3 ............................................. 15 Figure S17. HSQC (600 MHz, CD3OD) spectrum of compound 2 .................................................... 15 Figure S18. HMBC (600 MHz, CD3OD) spectrum of compound 2 ................................................... 16 Figure S19. 1H-1H COSY (600 MHz, CD3OD) spectrum of compound 2 ........................................... 16 Figure S20. The NOESY spectrum of compound 2 .......................................................................... 17 Figure S21. 1H-NMR (600 MHz, CD3OD) spectrum of compound 3 ................................................ 17 Figure S22. 13C-NMR (150 MHz, CD3OD) spectrum of compound 3 ............................................... 18 Figure S23. 1H-NMR (600 MHz, CD3OD) spectrum of compound 4 ................................................ 18 Figure S24. 13C-NMR (150 MHz, CD3OD) spectrum of compound 4 ............................................... 19\nTable S1. The 1H (600 MHz) and 13C NMR (150 MHz) spectral data of compound 1\nin CD3OD\nNo 1\n\u03b4C \u03b4H (J in Hz)\n1 2 124.6 7.12, s 3 108.5 4 119.4 7.46, d (8.0) 5 119.9 7.01, t (6.0) 6 122.4 7.11, t (6.0) 7 112.2 7.35, d (8.0) 8 32.2 3.74, s 9 174.3\n3a 128.6 7a 138.0 1\u2032 130.0\n2\u2032, 6\u2032 130.9 6.96, d (8.5) 3\u2032, 5\u2032 116.2 6.67, d (8.5)\n4\u2032 156.9 7\u2032 35.2 2.80, t (6.9) 8\u2032 66.9 4.24, t (6.9)\nTable S2. The 1H (600 MHz) and 13C NMR (150 MHz) spectral data of compounds\n24 in CD3OD\nNo 2 3 4\n\u03b4C \u03b4H (J in Hz) \u03b4C \u03b4H (J in Hz) \u03b4C \u03b4H (J in Hz)\n1 2 165.3 165.1 163.1 3 109.3 109.3 111.1 4 168.9 168.3 170.3 5 113.6 118.9 116.0 6 136.8 7.78, s 135.7 7.67, s 138.1 7.54, s 7 73.4 4.77, dd (11.7, 2.4) 73.5 4.75, dd (11.7, 2.3) 78.8 5.04, dd (11.0, 1.2) 8 30.7 2.21, m 30.7 2.21, m 31.7 1.67, m\n1.53, m 1.53, m 2.00, m\n9 33.9 1.92, m\n34.0 1.92, m\n33.3 1.74, m\n1.31, m 1.31, m 1.32, m\n10 31.9 1.60, m 32.9 1.60, m 33.5 1.75, m 11 93.0 3.38, d (9.8) 93.0 3.39, d (9.8) 93.8 3.65, d (10.1) 12 133.8 133.8 131.5 13 137.3 5.13, dd (9.5, 1.6) 137.2 5.14, dd (9.0, 0.6) 138.9 5.34, d (9.5) 14 30.1 2.51, m 30.1 2.51, m 30.8 2.54, m 15 46.2 1.22, m 46.2 1.06, m 46.2 1.26, m\n1.07, m 1.21, m 1.07, m\n16 33.3 1.40, m 33.3 1.30, m 33.3 1.32, m 17 29.9 1.42, m 29.9 1.40, m 29.8 1.41, m\n1.08, m 1.06, m 1.07, m\n18 11.5 0.88, d (7.4) 11.5 0.85, m 11.5 0.95, m 19 18.3 0.75, d (6.6) 18.3 0.75, d (6.6) 18.1 0.88, d (6.6) 20 11.5 1.58, d (1.1) 11.5 1.59, d (1.1) 12.0 1.75, d (1.2) 21 21.2 0.90, d (6.6) 21.2 0.90, d (6.6) 21.2 1.03, d (6.6) 22 20.1 0.87, d (6.6) 20.1 0.85, m 20.1 0.95, m 23 38.5 3.54, s 38.5 3.52, s 37.4 3.61, s 24 51.1 3.25, s 1\u2032 83.5 77.0 126.3 2\u2032 31.9 2.40, m 34.2 2.33, m\n131.5 7.35, d (8.6) 2.25, m 2.23, m\n3\u2032 35.8 2.35, m\n35.8 2.34, m\n116.0 6.88, d (8.6) 2.07, m 2.23, m\n4\u2032 210.2 210.2 158.1 5\u2032 49.0 3.33, m 49.4 3.30, m 116.0 6.88, d (8.6) 6\u2032 87.0 5.16, s 91.8 4.95, s 131.5 7.35, d (8.6)\nTable S3. Cytotoxicities (IC50 in M) for compounds 14\nCompound A172 A549 HepG2 Bel7402 HT29 PC3\n1 >10 >10 >10 >10 >10 >10 2 >10 >10 >10 >10 >10 >10 3 >10 >10 >10 >10 >10 >10 4 >10 >10 >10 >10 7.6 4.99\nDoxorubicin a 0.13 0.1 0.18 0.08 0.13 0.21 a Positive control\n1'\n6' 5'\n4'\n3' 2'\nOH\n7'\n8'\nO9 8\nO\n5\n6 7 7a\n3a 4\nN H 1\n2\n3\nHMBC 1H-1H COSY\nFigure S1. 1H\u22121H COSY and Key HMBC correlations of compound 1.\nA 5\n6 N\n3\n4 7 O\n8\n9\n10\n19\n11\n13\n14\n15\n16\n17\n18\n20 21 22\nOH 1'\n2'\n3'\n5'\nO\nOH\n23\nO\nOCH3 24\nB\nC\nD\n6'\n4'\n2\nHMBC 1H-1H COSY NOESY\nFigure S2. Key 1H\u22121H COSY, HMBC and NOESY correlations of compound 2\nFigure S3. HR-ESI-MS spectrum of compound 1\nFigure S4. UV spectrum of compound 1\nFigure S5. IR spectrum of compound 1\nFigure S6. 1H-NMR (600 MHz, CD3OD) spectrum of compound 1\nFigure S7. 13C-NMR (150 MHz, CD3OD) spectrum of compound 1\nFigure S8. HSQC (600 MHz, CD3OD) spectrum of compound 1\nFigure S9. 1H-1H COSY (600 MHz, CD3OD) spectrum of compound 1\nFigure S10. HMBC (600 MHz, CD3OD) spectrum of compound 1\nFigure S11. HR-ESI-MS spectrum of compound 2\nFigure S12. UV spectrum of compound 2\nFigure S13. IR spectrum of compound 2\nFigure S14. 1H-NMR (600 MHz, CD3OD) spectrum of compound 2\nFigure S15. 13C-NMR (150 MHz, CD3OD) spectrum of compound 2\nFigure S16. Comparative 13C-NMR spectrum of compounds 2 and 3\nFigure S17. HSQC (600 MHz, CD3OD) spectrum of compound 2\nFigure S18. HMBC (600 MHz, CD3OD) spectrum of compound 2\nFigure S19. 1H-1H COSY (600 MHz, CD3OD) spectrum of compound 2\nFigure S20. The NOESY spectrum of compound 2\nFigure S21. 1H-NMR (600 MHz, CD3OD) spectrum of compound 3\nFigure S22. 13C-NMR (150 MHz, CD3OD) spectrum of compound 3\nFigure S23. 1H-NMR (600 MHz, CD3OD) spectrum of compound 4\nFigure S24. 13C-NMR (150 MHz, CD3OD) spectrum of compound 4"
        }
    ],
    "title": "Alkaloids isolated from the endophytic fungus Fusarium concentricum",
    "year": 2022
}